Tianjin Medical University General Hospital

This study is testing if the drug eculizumab can help people with neuromyelitis optica spectrum disorder (NMOSD) during a sudden, severe attack. The drug is already approved to prevent these attacks, but researchers want to see if it can also stop damage and improve symptoms quic…

This study is testing whether adding a targeted drug (eculizumab) to standard treatment helps people recover better from sudden, severe attacks of neuromyelitis optica, a rare autoimmune disease that damages the optic nerves and spinal cord. About 198 adults who recently had an a…

This study aims to build a large national registry to better understand rare, inherited forms of diabetes in China. It will enroll up to 5,000 eligible participants who will use a mobile app or website to join and provide genetic samples. The main goal is to map out the genetic c…